Pauli Puolakkainen
Research Subjects
Research Interests
Pauli Puolakkainen has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- E. Kemppainen
Department of Surgery, Helsinki University Central Hospital, Finland
7 shared publications R Haapiainen
6 shared publicationsA Hietaranta
3 shared publicationsE. Kivilaakso
3 shared publicationsR. Haapiainen
3 shared publicationsA Leppäniemi
2 shared publications
Latest Publications
- 1 March 2013
- Published by Elsevier in Pancreatology
- Vol. 13 (2)
Anti-inflammatory macrophage induced MMP9 and ADAM8 expression increases invasion rate of pancreatic cancer cells
- 1 March 2013
- Published by Elsevier in Pancreatology
- Vol. 13 (2)
Anti-inflammatory macrophage induced MMP9 and ADAM8 expression increases invasion rate of pancreatic cancer cells
- 1 March 2013
- Published by Elsevier in Pancreatology
- Vol. 13 (2)
Cytokines as predictors of organ failure in severe acute pancreatitis
- 1 March 2013
- Published by Elsevier in Pancreatology
- Vol. 13 (2)
Cytokines as predictors of organ failure in severe acute pancreatitis
- 30 July 2002
- Vol. 49 (46) , 1130-4
Comparison of urine trypsinogen-2 test strip with serum lipase in the diagnosis of acute pancreatitis.
The accuracy of a new rapid urinary trypsinogen-2 test strip (actim Pancreatitis) was compared with that of serum lipase for detection of acute pancreatitis in patients with acute abdominal pain. A prospective study was conducted which consisted of 237 consecutive patients with acute abdominal pain admitted to the emergency unit at Helsinki University Central Hospital. The patients were tested on admission with the actim Pancreatitis test strip. Serum amylase, serum lipase, and urine trypsinogen-2 concentrations were also determined quantitatively. The actim Pancreatitis test strip result was positive in 27 out of 29 patients with acute pancreatitis (sensitivity 93%) and in 16 of 208 patients with non-pancreatic abdominal pain (specificity 92%). This was superior to that of serum lipase (sensitivity 79% and specificity 88%). With a cut-off > 3x the upper reference limit, the sensitivity of serum lipase was only 55% while the specificity was 99%. The high sensitivity for the actim Pancreatitis test strip resulted in a very high negative predictive value of 99%. All six patients with severe acute pancreatitis were detected by the dipstick. With a higher cut-off value (> 3x upper reference limit) for lipase, two patients with severe acute pancreatitis remained undetected. Combining the actim Pancreatitis dipstick with serum lipase a positive predictive value of 94% was obtained. Acute pancreatitis can be excluded with a higher probability with the actim Pancreatitis strip than with serum lipase determination, and therefore appears to be more suitable for screening of acute pancreatitis. With its high specificity with a cut-off > 3x the upper reference limit, serum lipase is suitable as a confirmatory test for pancreatitis when a positive dipstick result is obtained.
- 30 July 2002
- Vol. 49 (46) , 1130-4
Comparison of urine trypsinogen-2 test strip with serum lipase in the diagnosis of acute pancreatitis.
The accuracy of a new rapid urinary trypsinogen-2 test strip (actim Pancreatitis) was compared with that of serum lipase for detection of acute pancreatitis in patients with acute abdominal pain. A prospective study was conducted which consisted of 237 consecutive patients with acute abdominal pain admitted to the emergency unit at Helsinki University Central Hospital. The patients were tested on admission with the actim Pancreatitis test strip. Serum amylase, serum lipase, and urine trypsinogen-2 concentrations were also determined quantitatively. The actim Pancreatitis test strip result was positive in 27 out of 29 patients with acute pancreatitis (sensitivity 93%) and in 16 of 208 patients with non-pancreatic abdominal pain (specificity 92%). This was superior to that of serum lipase (sensitivity 79% and specificity 88%). With a cut-off > 3x the upper reference limit, the sensitivity of serum lipase was only 55% while the specificity was 99%. The high sensitivity for the actim Pancreatitis test strip resulted in a very high negative predictive value of 99%. All six patients with severe acute pancreatitis were detected by the dipstick. With a higher cut-off value (> 3x upper reference limit) for lipase, two patients with severe acute pancreatitis remained undetected. Combining the actim Pancreatitis dipstick with serum lipase a positive predictive value of 94% was obtained. Acute pancreatitis can be excluded with a higher probability with the actim Pancreatitis strip than with serum lipase determination, and therefore appears to be more suitable for screening of acute pancreatitis. With its high specificity with a cut-off > 3x the upper reference limit, serum lipase is suitable as a confirmatory test for pancreatitis when a positive dipstick result is obtained.
- 1 June 1998
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 36 (6) , 1808-1810
Positive Result by Serology Indicates Active Helicobacter pylori Infection in Patients with Atrophic Gastritis
Patients with atrophic corpus gastritis and elevatedHelicobacter pylori antibody titers but13C-urea breath test (13C-UBT) and histology results negative for H. pylori were randomized into eradication therapy or follow-up only. Antibody levels decreased significantly in six out of seven patients in the eradication group, while in the follow-up group, the titers declined in only one out of eight patients. In patients with atrophic corpus gastritis, positive serology results may indicate an ongoing infection in spite of negative13C-UBT and histology results.
- 1 June 1998
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 36 (6) , 1808-1810
Positive Result by Serology Indicates Active Helicobacter pylori Infection in Patients with Atrophic Gastritis
Patients with atrophic corpus gastritis and elevatedHelicobacter pylori antibody titers but13C-urea breath test (13C-UBT) and histology results negative for H. pylori were randomized into eradication therapy or follow-up only. Antibody levels decreased significantly in six out of seven patients in the eradication group, while in the follow-up group, the titers declined in only one out of eight patients. In patients with atrophic corpus gastritis, positive serology results may indicate an ongoing infection in spite of negative13C-UBT and histology results.
- 15 April 1998
- Published by Elsevier in Gastroenterology
- Vol. 114, A473
Bactericidal/permeability-increasing protein and group I and II phospholipase A2 during the induction phase of human acute pancreatitis
- 15 April 1998
- Published by Elsevier in Gastroenterology
- Vol. 114, A473
Bactericidal/permeability-increasing protein and group I and II phospholipase A2 during the induction phase of human acute pancreatitis
- 15 April 1998
- Published by Elsevier in Gastroenterology
- Vol. 114, A469-469
Extracellular phospholipases A2 in severe acute pancreatitis-associated systemic inflammatory response syndrome (SIRS)
- 15 April 1998
- Published by Elsevier in Gastroenterology
- Vol. 114, A469-469
Extracellular phospholipases A2 in severe acute pancreatitis-associated systemic inflammatory response syndrome (SIRS)
- 15 April 1998
- Published by Elsevier in Gastroenterology
- Vol. 114, A183-183
Positive serology indicates an active H. pylori infection in patients with atrophic gastritis in spite of negative histology and 13C-urea breath test
- 15 April 1998
- Published by Elsevier in Gastroenterology
- Vol. 114, A183-183
Positive serology indicates an active H. pylori infection in patients with atrophic gastritis in spite of negative histology and 13C-urea breath test
- 15 April 1998
- Published by Elsevier in Gastroenterology
- Vol. 114, A263
Natural course of atrophic gastritis: A prospective 6-year follow-up study
- 15 April 1998
- Published by Elsevier in Gastroenterology
- Vol. 114, A263
Natural course of atrophic gastritis: A prospective 6-year follow-up study
- 1 January 1998
- Vol. 87 (3) , 191-4
Diagnosis of acute pancreatitis.
There is no golden standard for the diagnosis of acute pancreatitis (AP). The diagnosis is currently based on clinical presentation, measurement of released pancreatic enzymes and imaging studies. Serum/urinary amylase, lipase and trypsinogen-2 dipstick are the most applicable methods in the clinical practice largely because of their simple, rapid, inexpensive and readily available assay methods. In addition to the clinical picture, inflammatory markers (CRP) or contrast enhanced CT can be used to assess the severity of acute pancreatitis. Multifactorial scoring systems (Ranson's prognostic signs, APACHE II, MOF-score) may be too cumbersome for clinical practice. Patient history, determination of AST, bilirubin and alkaline phosphatase levels as well as imaging studies such as ultrasonography and ERCP can be used to distinguish between biliary and non-biliary origin of the disease.
- 1 January 1998
- Vol. 87 (3) , 191-4
Diagnosis of acute pancreatitis.
There is no golden standard for the diagnosis of acute pancreatitis (AP). The diagnosis is currently based on clinical presentation, measurement of released pancreatic enzymes and imaging studies. Serum/urinary amylase, lipase and trypsinogen-2 dipstick are the most applicable methods in the clinical practice largely because of their simple, rapid, inexpensive and readily available assay methods. In addition to the clinical picture, inflammatory markers (CRP) or contrast enhanced CT can be used to assess the severity of acute pancreatitis. Multifactorial scoring systems (Ranson's prognostic signs, APACHE II, MOF-score) may be too cumbersome for clinical practice. Patient history, determination of AST, bilirubin and alkaline phosphatase levels as well as imaging studies such as ultrasonography and ERCP can be used to distinguish between biliary and non-biliary origin of the disease.
- 1 January 1998
- Vol. 87 (3) , 200-3
Current principles of treatment in acute pancreatitis.
The treatment of mild acute pancreatitis (AP) with fluid replacement and other conservative measures is adequate and sufficient in the majority of patients. The corner-stones of the treatment of patients with severe acute pancreatitis include early aggressive fluid resuscitation, intensive care with close monitoring and support of organ function, antibiotic prophylaxis, early supportive treatment of organ failure, and surgery in selected cases with infected pancreatic necrosis or deterioration of patient's condition in spite of maximal conservative therapy. Early endoscopic removal of common bile duct stones should be considered in cases with biliary AP. Altogether, increased accuracy in early diagnosis and development of intensive care have resulted in a significant decrease in mortality of patients with severe pancreatitis. In this paper, we review the current principles and methods of treatment in acute pancreatitis at Helsinki University Central Hospital.
- 1 January 1998
- Vol. 87 (3) , 200-3
Current principles of treatment in acute pancreatitis.
The treatment of mild acute pancreatitis (AP) with fluid replacement and other conservative measures is adequate and sufficient in the majority of patients. The corner-stones of the treatment of patients with severe acute pancreatitis include early aggressive fluid resuscitation, intensive care with close monitoring and support of organ function, antibiotic prophylaxis, early supportive treatment of organ failure, and surgery in selected cases with infected pancreatic necrosis or deterioration of patient's condition in spite of maximal conservative therapy. Early endoscopic removal of common bile duct stones should be considered in cases with biliary AP. Altogether, increased accuracy in early diagnosis and development of intensive care have resulted in a significant decrease in mortality of patients with severe pancreatitis. In this paper, we review the current principles and methods of treatment in acute pancreatitis at Helsinki University Central Hospital.